Genetically Determined Cardiovascular Disease
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular Genetics and Genetic Diseases".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 6
Special Issue Editor
Interests: cardiovascular disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Genetically determined cardiovascular diseases (CVDs) encompass a spectrum of disorders rooted in hereditary predispositions, including monogenic mutations and polygenic risk factors. These conditions, such as familial hypercholesterolemia, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy, often manifest early in life and confer elevated risks of myocardial infarction, sudden cardiac death, or heart failure. Advances in genomic sequencing have unveiled critical genetic variants (e.g., LDLR, MYH7, and PKP2) that disrupt lipid metabolism, myocardial contraction, or cardiac electrophysiology. Epigenetic modifiers and gene–environment interactions further modulate disease penetrance, underscoring the complexity of inherited CVD pathogenesis.
This Special Issue welcomes comprehensive reviews and original research articles that explore cutting-edge diagnostic and therapeutic strategies, including polygenic risk scoring, CRISPR-based gene editing, and targeted pharmacotherapies. Contributions may also address challenges in genetic counseling, the ethical implications of predictive testing, and the integration of multi-omics data to refine precision medicine approaches.
Dr. Gaetano Thiene
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genetically determined cardiovascular diseases
- genetic mutations
- oligogenic inheritance
- congenital heart defects
- atherosclerosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
